09 Jun 2025
Executive Summary The Patented Medicines Prices Review Board (PMPRB) is undergoing a significant transformation in its approach to pharmaceutical pricing guidelines. This white paper explores the comprehensive consultation process that is reshaping the organization’s methodology for monitoring and reviewing drug …...
07 Apr 2025
The Canadian drug landscape is undergoing a transformative shift, and pharmaceutical manufacturers need a strategic playbook to succeed. Here are seven insider secrets to help you navigate the Canada’s Drug Agency’s (CDA) new mandate: 1. Embrace Real-World Evidence Early …...
07 Apr 2025
In a recent panel discussion on pharmaceutical access, healthcare experts revealed critical insights into how technology could revolutionize healthcare equity. Here are four groundbreaking trends that promise to reshape how Canadians access medical care: Intelligent Telehealth Beyond Urban Centers The …...
22 May 2025
The introduction of Canada’s national PharmaCare program has created a complex environment for pharmaceutical companies developing innovative medicines. Here are three strategic approaches to navigate this uncertain terrain: Proactive Engagement with Policy Makers As the landscape of healthcare continues to …...
07 Apr 2025
In the rapidly evolving landscape of healthcare innovation, breakthrough therapies are emerging faster than ever—but there’s a critical bottleneck preventing patients from accessing these life-changing treatments. Enter Outcome-Based Agreements (OBAs), a strategic approach that’s poised to transform how we think …...
07 Apr 2025
A Comprehensive Analysis of Systemic Barriers and Transformative Strategies Executive Summary: The healthcare landscape for First Nations communities in Canada represents a critical intersection of technological innovation, policy reform, and social equity. This whitepaper examines the complex challenges and presents …...
Loading...
